Stock research
NCEL NewcelX Ltd.
Healthcare • Biotechnology
NewcelX Ltd., a biotechnology firm established in 2008 and based in Zurich, Switzerland, is dedicated to advancing groundbreaking therapeutic solutions. The company's focus lies in developing innovative treatments,...…
NewcelX Ltd., a biotechnology firm established in 2008 and based in Zurich, Switzerland, is dedicated to advancing groundbreaking therapeutic solutions. The company's focus lies in developing innovative treatments, utilizing both cell-based and small-molecule approaches, to address challenging neurodegenerative and metabolic diseases.
1Y change
-81.03%
Range high
$27.90
Congress · 90d
0
Insiders · 90d
0
Public signal layer
Who is disclosing activity in NCEL?
Price
Showing 1Y history. Source: FMP historical price full.
- Prev Close
- $3.36
- Day High
- $3.68
- Day Low
- $3.36
- 52w High
- $28.03
- 52w Low
- $1.83
- Volume
- 10,099
- Avg Volume
- Beta
- 0.9208419
* TTM/most recent where available
Company
- Ticker
- NCEL
- Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- CH
- CEO
- Ronen Twito
- Employees
- 11
- Website
- newcelx.net
Key Metrics
- Market Cap
- 1.57M
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price
DCF vs Price (30D window)
Price uses last 30 days; DCF line holds latest value across the window.DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).